World Health Organization
 Collaborating Center on
 Pharmaceutical Policy

    Improving Access to and Use of Essential Medicines

  Contact Info  


Learn More About:
> Medicines and Insurance Coverage (MedIC) Initiative

> Overview
> Activities

Medicines Transparency Alliance (MeTA)

During 2007, the United Kingdom Department for International Development (DfID), in partnership with WHO and other international agencies, has been developing the Medicines Transparency Alliance (MeTA) – an international multi-stakeholder alliance to promote transparency in the supply of essential medicines, with the aim of improving access to affordable essential drugs in developing countries. MeTA’s focus will be on the collection, analysis, dissemination and use of data on medicine quality, availability, affordability, and access. This will help improve transparency in the way medicines are procured, distributed, and supplied to consumers and patients. It is expected that MeTA will be comprised of 3 major components: country level pilot projects, global public health goods, and an academic research observatory. Dennis Ross-Degnan and Brenda Waning from the CCPP have been actively engaged with MeTA at country and global level to assist in the design and implementation of MeTA.

Planned CCPP activities under MeTA include:
  • Continued assessment of prices of medicines purchased through the Global Fund and other global initiatives
  • Development, testing, and implementation of an assessment framework to evaluate the impacts of MeTA over time
  • Contribution of methods and tools to the global repository of information on medicines
  • Technical assistance to MeTA country projects which will likely focus on medicines price, quality, and affordability


WHOCCPP awarded funding for Interdisciplinary Research and Training for Improving Access to and Use of Medicines in China by Harvard China Fund

Upcoming Courses

MedIC Initiative Courses in Accra, Ghana, November 16-25, 2008 and Beijing, China in the Spring of 2009